Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
PLoS Genet
    February 2024
  1. SCOTT TG, Sathyan KM, Gioeli D, Guertin MJ, et al
    TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER) binding and ER target gene expression in luminal breast cancer cells.
    PLoS Genet. 2024;20:e1011159.
    >> Share

    November 2023
  2. CARPENTER MA, Temiz NA, Ibrahim MA, Jarvis MC, et al
    Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.
    PLoS Genet. 2023;19:e1011043.
    >> Share

    September 2023
  3. WANG J, Chen Y, Zou Q
    Inferring gene regulatory network from single-cell transcriptomes with graph autoencoder model.
    PLoS Genet. 2023;19:e1010942.
    >> Share

  4. SAHU S, Sullivan TL, Mitrophanov AY, Galloux M, et al
    Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants.
    PLoS Genet. 2023;19:e1010940.
    >> Share

    August 2023
  5. KUMPULA TA, Vorimo S, Mattila TT, O'Gorman L, et al
    Exome sequencing identified rare recurrent copy number variants and hereditary breast cancer susceptibility.
    PLoS Genet. 2023;19:e1010889.
    >> Share

  6. DIABATE M, Islam MM, Nagy G, Banerjee T, et al
    DNA repair function scores for 2172 variants in the BRCA1 amino-terminus.
    PLoS Genet. 2023;19:e1010739.
    >> Share

    July 2023
  7. LIU W, Deng W, Chen M, Dong Z, et al
    A statistical framework to identify cell types whose genetically regulated proportions are associated with complex diseases.
    PLoS Genet. 2023;19:e1010825.
    >> Share

    January 2023
  8. FERRANDO L, Vingiani A, Garuti A, Vernieri C, et al
    ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC).
    PLoS Genet. 2023;19:e1010563.
    >> Share

    September 2022
  9. LUONG TT, Li Z, Priedigkeit N, Parker PS, et al
    Hrq1/RECQL4 regulation is critical for preventing aberrant recombination during DNA intrastrand crosslink repair and is upregulated in breast cancer.
    PLoS Genet. 2022;18:e1010122.
    >> Share

    June 2022
  10. SANCHEZ VC, Yang HH, Craig-Lucas A, Dubois W, et al
    Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competence.
    PLoS Genet. 2022;18:e1010271.
    >> Share

    January 2022
  11. HAYES BL, Robinson T, Kar S, Ruth KS, et al
    Do sex hormones confound or mediate the effect of chronotype on breast and prostate cancer? A Mendelian randomization study.
    PLoS Genet. 2022;18:e1009887.
    >> Share

    December 2021
  12. GUILLON J, Coquelet H, Leman G, Toutain B, et al
    tRNA biogenesis and specific aminoacyl-tRNA synthetases regulate senescence stability under the control of mTOR.
    PLoS Genet. 2021;17:e1009953.
    >> Share

    November 2021
  13. MADSEN RR, Erickson EC, Rueda OM, Robin X, et al
    Positive correlation between transcriptomic stemness and PI3K/AKT/mTOR signaling scores in breast cancer, and a counterintuitive relationship with PIK3CA genotype.
    PLoS Genet. 2021;17:e1009876.
    >> Share

    September 2021
  14. FRITSCHE LG, Ma Y, Zhang D, Salvatore M, et al
    On cross-ancestry cancer polygenic risk scores.
    PLoS Genet. 2021;17:e1009670.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016